ASXL1 mutation is one of the most frequently observed mutations leading to clonal hematopoiesis (CH), which have been known to show elevated inflammation, impaired tumor suppressor function, and risk of eventual hematological malignancy (HM)34–36. The gene discussed is ASXL1; the disease is cyclic hematopoiesis.